Data-driven discovery of innate immunomodulators <i>via</i> machine learning-guided high throughput screening

Yifeng Tang, Jeremiah Kim, Carman KM IP, Azadeh Bahmani, Qing Chen, Matthew G. Rosenberger, Aaron P. Esser‐Kahn, Andrew L. Ferguson

Chemical Science · 2023 · 14 citations · 45 references

DOIFull text

Open access

Concepts

Abstract

HTS, we performed an active learning-guided traversal of a 139 998 molecule library. After sampling only ∼2% of the library, we discovered viable molecules with unprecedented immunomodulatory capacity, including those capable of suppressing NF-κB activity by up to 15-fold, elevating NF-κB activity by up to 5-fold, and elevating IRF activity by up to 6-fold. We extracted chemical design rules identifying particular chemical fragments as principal drivers of specific immunomodulation behaviors. We validated the immunomodulatory effect of a subset of our top candidates by measuring cytokine release profiles. Of these, one molecule induced a 3-fold enhancement in IFN-β production when delivered with a cyclic di-nucleotide stimulator of interferon genes (STING) agonist. In sum, our machine learning-enabled screening approach presents an efficient immunomodulator discovery pipeline that has furnished a library of novel small molecules with a strong capacity to enhance or suppress innate immune signaling pathways to shape and improve prophylactic vaccination and immunotherapies.

References

45